Abstract
In most rheumatic diseases, the homeostasis of bone formation and degradation is disrupted through different mechanisms driven by inflammatory mediators, biomechanical factors, and genetic abnormalities. Osteoarthritis is one of the leading causes of disability in adults worldwide. It is a degenerative disease of the joints secondary to many predisposing factors, most notably age, joint injury, altered mechanical stress, and obesity. All these processes cause a local chronic inflammatory response resulting in the progressive joint failure characteristic of OA. Osteoporosis is the result of cumulative bone loss during aging. Nevertheless, a wide variety of diseases, medications, and lifestyles can cause or contribute to the development of osteoporosis. In addition, the immune system participates in the regulation of bone homeostasis through production of cytokines and inflammatory mediators with subsequent activation of cartilage-degrading proteinases. Paget’s disease is a chronic skeletal disorder, caused by enhanced bone resorption followed by abnormal bone formation, in which a potential cross talk between the bone and the immune system takes place.
Hereditary connective tissue diseases (e.g., Marfan’s syndrome, Ehlers-Danlos syndromes, osteogenesis imperfecta) are a heterogeneous group of disorders that result from genetic defects that alter the quantity or structure of extracellular matrix proteins. These disorders can present with various clinical manifestations involving the musculoskeletal, cardiovascular, respiratory, and ocular systems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
de Lange-Brokaar BJ, Ioan-Facsinay A, van Osch GJ, Zuurmond AM, Schoones J, Toes RE, et al. Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review. Osteoarthr Cartil. 2012;20:1484–99.
Nguyen C, Boutron I, Baron G, Sanchez K, Palazzo C, Benchimol R, et al. Intradiscal glucocorticoid injection for patients with chronic low back pain associated with active discopathy: a randomized trial. Ann Intern Med. 2017;166:547–56. https://doi.org/10.7326/M16-1700.
Bolton JM, Morin SN, Majumdar SR, Sareen J, Lix LM, Johansson H, et al. Association of mental disorders and related medication use with risk for major osteoporotic fractures. JAMA Psychiat. 2017;74:641–8. https://doi.org/10.1001/jamapsychiatry.2017.0449.
Mont MA, Cherian JJ, Sierra RJ, Jones LC, Lieberman JR. Nontraumatic osteonecrosis of the femoral head: where do we stand today? A ten-year update. J Bone Joint Surg Am. 2015;97:1604–27. https://doi.org/10.2106/JBJS.O.00071.
Ottaviani S, Ayral X, Dougados M, Gossec L. Pigmented villonodular synovitis: a retrospective single-center study of 122 cases and review of the literature. Semin Arthritis Rheum. 2011;40:539–46. https://doi.org/10.1016/j.semarthrit.2010.07.005.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Moutsopoulos, H.M., Zampeli, E., Vlachoyiannopoulos, P.G. (2018). Bone, Cartilage, and Soft Tissue Disorders. In: Rheumatology in Questions. Springer, Cham. https://doi.org/10.1007/978-3-319-71604-6_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-71604-6_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-71603-9
Online ISBN: 978-3-319-71604-6
eBook Packages: MedicineMedicine (R0)